Optimizing the Use of Inhaled Corticosteroid/Long-Acting β(2)-Agonist Combinations in Patients with Moderate-to-Severe Asthma.

Garcia G, Maneechotesuwan K, Krishnan P, Verma M, Roche N

Open source

DOI
10.1007/s12325-025-03406-1
Published
2026 Feb
Container
Advances in therapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12325-025-03406-1,
  title = {Optimizing the Use of Inhaled Corticosteroid/Long-Acting β(2)-Agonist Combinations in Patients with Moderate-to-Severe Asthma.},
  author = {Garcia G and Maneechotesuwan K and Krishnan P and Verma M and Roche N},
  year = {2026},
  journal = {Advances in therapy},
  doi = {10.1007/s12325-025-03406-1},
  url = {https://doi.org/10.1007/s12325-025-03406-1}
}

RIS

TY  - JOUR
TI  - Optimizing the Use of Inhaled Corticosteroid/Long-Acting β(2)-Agonist Combinations in Patients with Moderate-to-Severe Asthma.
AU  - Garcia G
AU  - Maneechotesuwan K
AU  - Krishnan P
AU  - Verma M
AU  - Roche N
PY  - 2026
JO  - Advances in therapy
DO  - 10.1007/s12325-025-03406-1
UR  - https://doi.org/10.1007/s12325-025-03406-1
ER  - 

APA

G, G., K, M., P, K., M, V., & N, R. (2026). Optimizing the Use of Inhaled Corticosteroid/Long-Acting β(2)-Agonist Combinations in Patients with Moderate-to-Severe Asthma.. Advances in therapy. https://doi.org/10.1007/s12325-025-03406-1

Source records